About the Authors
- Richa Sharma
-
* E-mail: rsharm23@jhmi.edu (RS); shawn.acheson@duke.edu (SKA)
Affiliation School of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America
- Alexandra Rosenberg
-
Affiliation School of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America
- Ellen R. Bennett
-
Affiliation Department of Neurology, Duke University Medical Center, Durham, North Carolina, United States of America
- Daniel T. Laskowitz
-
Affiliations School of Medicine, Duke University Medical Center, Durham, North Carolina, United States of America, Department of Neurology, Duke University Medical Center, Durham, North Carolina, United States of America
- Shawn K. Acheson
-
* E-mail: rsharm23@jhmi.edu (RS); shawn.acheson@duke.edu (SKA)
Affiliations Durham VA Medical Center, Durham, North Carolina, United States of America, Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina, United States of America
Competing Interests
Dr. Laskowitz serves as a consultant for Astute Medical, Inc., which performed the antibody-based assays used in this study. The study was subsidized by a research grant from Astute Medical, Inc. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceptualization: RS DTL. Data curation: RS DTL SKA. Formal analysis: RS DTL SKA. Funding acquisition: DTL. Investigation: RS DTL. Methodology: RS ERB DTL SKA. Project administration: ERB DTL. Resources: ERB DTL. Supervision: ERB DTL. Validation: RS AR ERB DTL SKA. Visualization: RS SKA. Writing – original draft: RS AR SKA. Writing – review & editing: RS AR ERB DTL SKA.